Document is current
Any future updates will be listed below
-
Authors
Huang, Ye
Nguyen, Nam V.
Fashina, Tolulope
Kaftan, Timothy https://orcid.org/0009-0003-9867-0909
Lobo-Chan, Ann-Marie
Conrady, Christopher D.
Yeh, Steven
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (K08 EY034892)
College of Medicine, University of Nebraska Medical Center
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01 EY029594)
Association for Research in Vision and Ophthalmology
- License Information
-
More Information
Article History
Received: 24 March 2025
Revised: 4 August 2025
Accepted: 18 September 2025
First Online: 1 October 2025
Competing interests
: No conflicting relationship exists for any author. YH, NVN, TF, and TK have no financial disclosures to declare. AMLC receives consulting fees from Bausch Health and serves as an advisory board for Alimera. CDC has a provisional patent NIN #24087 for the intravitreal use of IFN-alpha. SY receives consulting fees from Alcon, Bausch and Lomb, Adverum, Apellis, and Eyepoint.
: This article was conducted in accordance with the Declaration of Helsinki. The collection and evaluation of all protected patient health information was performed in a Health Insurance Portability and Accountability Act (HIPAA)-compliant manner.
